AEMD - Aethlon Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
110
230
150
392
887
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
6,933
6,229
4,981
6,490
5,271
Total Operating Expenses
6,933
6,229
4,981
6,490
5,271
Operating Income or Loss
-6,823
-5,999
-4,831
-6,098
-4,385
Interest Expense
164
220
362
304
574
Total Other Income/Expenses Net
-
-
-507
-904
0
Income Before Tax
-7,439
-6,220
-5,700
-7,307
-4,959
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-7,439
-6,220
-5,700
-7,307
-4,959
Net Income
-7,427
-6,195
-5,680
-7,276
-4,872
Net Income available to common shareholders
-7,427
-6,195
-5,680
-7,276
-4,872
Reported EPS
Basic
-
-5.10
-6.90
-14.10
-9.90
Diluted
-
-5.10
-6.90
-14.10
-9.90
Weighted average shares outstanding
Basic
-
1,208
821
518
493
Diluted
-
1,208
821
518
493
EBITDA
-
-5,968
-5,303
-6,970
-4,346